U. Şahin

Effect of bevacizumab on postoperative adhesion formation in a rat uterine horn adhesion model and the correlation with vascular endothelial growth factor and Ki-67 immunopositivity.

M. Çaydere, S. Kılıc, S. Batıoğlu, 2011, Fertility and sterility.

1558O COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine

N. Kitchin, S. Lockhart, R. Bailey, 2021, Annals of Oncology.

Cancer esearch or and Stem Cell Biology astasis-Associated Protein 1 Short Form Stimulates Wnt 1 R hway in Mammary Epithelial and Cancer Cells

K. Ohshiro, S. Rayala, S. Pakala, 2010 .

155P BNT113 + pembrolizumab as first-line treatment in patients with unresectable recurrent/metastatic HNSCC: Preliminary safety data from AHEAD-MERIT

A. Atasoy, Ö. Türeci, R. Greil, 2022, Immuno-Oncology and Technology.

A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma.

J. Utikal, M. Gaiser, Ö. Türeci, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

LBA38 BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours

C. Bokemeyer, A. Mackensen, Ö. Türeci, 2022, Annals of Oncology.

LBA1 BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+ advanced solid tumors

A. Mackensen, Ö. Türeci, J. Haanen, 2021, Annals of Oncology.